EUVIMEDEUVIMED entdecken
KommentarOpen Access

Gap resection matters in BRCA mutant cancer

Lee Zou

Genes & Development · 01.05.2025 · 39 (9-10) · 539-540

DOI: 10.1101/gad.352827.125 ↗

Kurz gefasst

Kommentar in der Zeitschrift Genes & Development, online erschienen am 10.04.2025. Verfasst von Lee Zou. Beteiligte Einrichtung: Department of Pharmacology and Cancer Biology, Duke University School of Medicine, Durham, North Carolina 27710, USA lee.zou@duke.edu. Hauptthemen laut MEDLINE: BRCA1 Protein, DNA Repair, Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer cells deficient in BRCA1/2 have impaired DNA repair, making them sensitive to PARP inhibitors (PARPis). In this issue of Genes & Development , Seppa and colleagues (doi:10.1101/gad.352421.124) investigated how BRCA1 protects single-stranded DNA gaps from nucleolytic processing. They showed that PARPi-induced gaps are rapidly resected by several exonucleases bidirectionally and filled by translesion synthesis. In BRCA1-deficient cells, gaps become larger and persistent due to excessive resection. These gaps do not convert to DNA double-stranded breaks (DSBs) via endonuclease activity but cause DSBs through replication fork collisions in a cell cycle-dependent manner. This research clarifies how BRCA1 loss contributes to PARPi sensitivity in BRCA mutant tumors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BRCA1 ProteinDNA RepairNeoplasmsFemaleHumansBRCA2 ProteinDNA Breaks, Double-StrandedMutationPoly(ADP-ribose) Polymerase Inhibitors

Stichwörter der Autor:innen

BRCADNA replicationDNA replication stressMRE11PARP inhibitorgenome stabilitynucleasessingle-stranded DNA gaps

Substanzen

BRCA1 ProteinBRCA2 ProteinPoly(ADP-ribose) Polymerase Inhibitors

Autor:innen und Institutionen

  • Department of Pharmacology and Cancer Biology, Duke University School of Medicine, Durham, North Carolina 27710, USA lee.zou@duke.edu.

Förderung

  • NCI NIH HHS

Zitieren

APA

Zou, L. (2025). Gap resection matters in BRCA mutant cancer. Genes & Development, 39(9-10), 539-540. https://doi.org/10.1101/gad.352827.125

Vancouver

Zou L. Gap resection matters in BRCA mutant cancer. Genes & Development. 2025;39(9-10):539-540. doi:10.1101/gad.352827.125

BibTeX
@article{Zou2025,
  author = {Zou, Lee},
  title = {Gap resection matters in BRCA mutant cancer},
  journal = {Genes & Development},
  year = {2025},
  volume = {39},
  number = {9-10},
  pages = {539--540},
  doi = {10.1101/gad.352827.125}
}
Kostenlos starten →